{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:39:08Z","timestamp":1792370348880,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s40618-019-01141-3","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T20:02:41Z","timestamp":1572984161000},"page":"401-411","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Orbital diseases mimicking graves\u2019 orbitopathy: a long-standing challenge in differential diagnosis"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0365-116X","authenticated-orcid":false,"given":"M.","family":"Marin\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Ionni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lanzolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sframeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Latrofa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Marcocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,5]]},"reference":[{"key":"1141_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, Perros P, Salvi M, Wiersinga WM, European Group on Graves\u2019 Orbitopathy (EUGOGO) (2016) The 2016 European Thyroid Association\/European Group on Graves\u2019 orbitopathy guidelines for the management of Graves\u2019 Orbitopathy. Eur Thyroid J 5:9\u201326","journal-title":"Eur Thyroid J"},{"key":"1141_CR2","first-page":"444","volume":"36","author":"E Piantanida","year":"2013","unstructured":"Piantanida E, Tanda ML, Lai A, Sassi L, Bartalena L (2013) Prevalence and natural history of Graves\u2019 orbitopathy in the XXI century. J Endocrinol Invest 36:444\u2013449","journal-title":"J Endocrinol Invest"},{"key":"1141_CR3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/thy.2014.0475","volume":"25","author":"M Leo","year":"2015","unstructured":"Leo M, Menconi F, Rocchi R, Latrofa F, Sisti E, Profilo MA, Mazzi B, Albano E, Nardi M, Vitti P, Marcocci C, Marin\u00f2 M (2015) Role of the underlying thyroid disease on the phenotype of Graves\u2019 orbitopathy in a tertiary referral center. Thyroid 25:347\u2013351","journal-title":"Thyroid"},{"key":"1141_CR4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/acta.0.1200473","volume":"120","author":"C Marcocci","year":"1989","unstructured":"Marcocci C, Bartalena L, Bogazzi F, Panicucci M, Pinchera A (1989) Studies on the occurrence of ophthalmopathy in Graves\u2019 disease. Acta Endocrinol (Copenh) 120:473\u2013478","journal-title":"Acta Endocrinol (Copenh)"},{"key":"1141_CR5","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0035-1555762","volume":"47","author":"RS Bahn","year":"2015","unstructured":"Bahn RS (2015) Current insights into the pathogenesis of Graves\u2019 ophthalmopathy. Horm Metab Res 47:773\u2013778","journal-title":"Horm Metab Res"},{"issue":"27","key":"1141_CR6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF03345271","volume":"2004","author":"M Marin\u00f2","year":"2004","unstructured":"Marin\u00f2 M, Chiovato L, Lisi S, Altea MA, Marcocci C, Pinchera A (2004) Role of thyroglobulin in the pathogenesis of Graves\u2019 ophthalmopathy: the hypothesis of Kriss revisited. J Endocrinol Invest 2004(27):230\u2013236","journal-title":"J Endocrinol Invest"},{"key":"1141_CR7","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000500297","volume":"8","author":"C Rodia","year":"2019","unstructured":"Rodia C, Menconi F, Mazoni L, Torregrossa L, Basolo F, Vitti P, Marcocci C, Marin\u00f2 M (2019) A case of unilateral dermopathy possibly related to Graves\u2019 disease. Eur Thyroid J 8:278\u2013282 (in press)","journal-title":"Eur Thyroid J"},{"key":"1141_CR8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamaophthalmol.2018.0806","volume":"136","author":"G Rotondo Dottore","year":"2018","unstructured":"Rotondo Dottore G, Torregrossa L, Caturegli P, Ionni I, Sframeli A, Sabini E, Menconi F, Piaggi P, Sellari-Franceschini S, Nardi M, Latrofa F, Vitti P, Marcocci C, Basolo F, Marin\u00f2 M (2018) Association of T and B cells infiltrating orbital tissues with clinical features of Graves orbitopathy. JAMA Ophthalmol 136:613\u2013619","journal-title":"JAMA Ophthalmol"},{"key":"1141_CR9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/thy.2016.0397","volume":"27","author":"G Rotondo Dottore","year":"2017","unstructured":"Rotondo Dottore G, Leo M, Casini G, Latrofa F, Cestari L, Sellari-Franceschini S, Nardi M, Vitti P, Marcocci C, Marin\u00f2 M (2017) Anti-oxidant actions of selenium in orbital fibroblasts: a basis for the effects of selenium in Graves\u2019 orbitopathy. Thyroid 27:271\u2013278","journal-title":"Thyroid"},{"key":"1141_CR10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s40618-017-0718-7","volume":"41","author":"G Rotondo Dottore","year":"2018","unstructured":"Rotondo Dottore G, Ionni I, Menconi F, Casini G, Sellari-Franceschini S, Nardi M, Vitti P, Marcocci C, Marin\u00f2 M (2018) Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves\u2019 Orbitopathy (GO): a new frontier for GO treatment? J Endocrinol Invest 41:193\u2013201","journal-title":"J Endocrinol Invest"},{"key":"1141_CR11","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s40618-017-0809-5","volume":"41","author":"G Rotondo Dottore","year":"2018","unstructured":"Rotondo Dottore G, Ionni I, Menconi F, Casini G, Sellari-Franceschini S, Nardi M, Vitti P, Marcocci C, Marin\u00f2 M (2018) Antioxidant effects of \u03b2-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves\u2019 orbitopathy (GO). J Endocrinol Invest 41:815\u2013820","journal-title":"J Endocrinol Invest"},{"key":"1141_CR12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/er.2018-00066","volume":"40","author":"TJ Smith","year":"2019","unstructured":"Smith TJ, Janssen JAMJL (2019) Insulin-like growth factor-I receptor and thyroid-associated ophthalmopathy. Endocr Rev 40:236\u2013267","journal-title":"Endocr Rev"},{"key":"1141_CR13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s40618-018-0943-8","volume":"42","author":"M Marin\u00f2","year":"2019","unstructured":"Marin\u00f2 M, Rotondo Dottore G, Ionni I, Lanzolla G, Sabini E, Ricci D, Sframeli A, Mazzi B, Menconi F, Latrofa F, Vitti P, Marcocci C, Chiovato L (2019) Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves\u2019 disease and Graves\u2019 orbitopathy. J Endocrinol Invest 42:471\u2013480","journal-title":"J Endocrinol Invest"},{"key":"1141_CR14","first-page":"168","volume":"21","author":"L Bartalena","year":"2000","unstructured":"Bartalena L, Pinchera A, Marcocci C (2000) Management of Graves\u2019 ophthalmopathy: reality and perspectives. Endocr Rev 21:168\u2013199","journal-title":"Endocr Rev"},{"key":"1141_CR15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.beem.2011.11.007","volume":"26","author":"PJ Dolman","year":"2012","unstructured":"Dolman PJ (2012) Evaluating Graves\u2019 orbitopathy. Best Pract Res Clin Endocrinol Metab 26:229\u2013248","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1141_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","volume":"47","author":"MP Mourits","year":"1997","unstructured":"Mourits MP, Prummel MF, Wiersinga WM, Koornneef L (1997) Clinical activity score as a guide in the management of patients with Graves\u2019 ophthalmopathy. Clin Endocrinol (Oxf) 47:9\u201314","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1141_CR17","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","volume":"364","author":"C Marcocci","year":"2011","unstructured":"Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Prummel M, Stahl M, Altea MA, Nardi M, Pitz S, Boboridis K, Sivelli P, von Arx G, Mourits MP, Baldeschi L, Bencivelli W, Wiersinga W, European Group on Graves\u2019 Orbitopathy (2011) Selenium and the course of mild Graves\u2019 orbitopathy. N Engl J Med 364:1920\u20131931","journal-title":"N Engl J Med"},{"issue":"4S Suppl 1","key":"1141_CR18","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1097\/IOP.0000000000001136","volume":"34","author":"M Marin\u00f2","year":"2018","unstructured":"Marin\u00f2 M, Menconi F, Rotondo Dottore G, Leo M, Marcocci C (2018) Selenium in Graves\u2019 Hyperthyroidism and Orbitopathy. Ophthal Plast Reconstr Surg 34(4S Suppl 1):S105\u2013S110","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"1141_CR19","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1055\/a-0658-7889","volume":"50","author":"M Marin\u00f2","year":"2018","unstructured":"Marin\u00f2 M, Dottore GR, Leo M, Marcocci C (2018) Mechanistic pathways of selenium in treatment for Graves\u2019 disease and Graves\u2019 orbitopathy. Horm Metab Res 50:887\u2013893","journal-title":"Horm Metab Res"},{"key":"1141_CR20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40618-017-0608-z","volume":"40","author":"L Bartalena","year":"2017","unstructured":"Bartalena L, Veronesi G, Krassas GE, Wiersinga WM, Marcocci C, Marin\u00f2 M, Salvi M, Daumerie C, Bournaud C, Stahl M, Sassi L, Azzolini C, Boboridis KG, Mourits MP, Soeters MR, Baldeschi L, Nardi M, Curr\u00f2 N, Boschi A, Bernard M, von Arx G, Perros P, Kahaly GJ, European Group on Graves\u2019 Orbitopathy (EUGOGO) (2017) Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves\u2019 orbitopathy? J Endocrinol Invest 40:547\u2013553","journal-title":"J Endocrinol Invest"},{"key":"1141_CR21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s40618-015-0241-7","volume":"38","author":"E Sisti","year":"2015","unstructured":"Sisti E, Menconi F, Leo M, Profilo MA, Mautone T, Mazzi B, Rocchi R, Latrofa F, Nardi M, Vitti P, Marcocci C, Marin\u00f2 M (2015) Long term outcome of Graves\u2019 orbitopathy following high dose intravenous glucocorticoids and orbital radiotherapy. J Endocrinol Invest 38:661\u2013668","journal-title":"J Endocrinol Invest"},{"key":"1141_CR22","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1530\/EJE-16-0552","volume":"176","author":"MN Stan","year":"2016","unstructured":"Stan MN, Salvi M (2016) Management of endocrine diseASE: Rituximab therapy for Graves\u2019 orbitopathy\u2014lessons from randomized control trials. Eur J Endocrinol 176:R101\u2013R109","journal-title":"Eur J Endocrinol"},{"key":"1141_CR23","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","volume":"376","author":"TJ Smith","year":"2017","unstructured":"Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, Tang RA, Harris GJ, Antonelli A, Salvi M, Goldberg RA, Gigantelli JW, Couch SM, Shriver EM, Hayek BR, Hink EM, Woodward RM, Gabriel K, Magni G, Douglas RS (2017) Teprotumumab for thyroid-associated ophthalmopathy. N Engl J Med 376:1748\u20131761","journal-title":"N Engl J Med"},{"key":"1141_CR24","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s40618-017-0717-8","volume":"40","author":"E Piantanida","year":"2017","unstructured":"Piantanida E, Bartalena L (2017) Teprotumumab: a new avenue for the management of moderate-to-severe and active Graves\u2019 orbitopathy? J Endocrinol Invest 40:885\u2013887","journal-title":"J Endocrinol Invest"},{"key":"1141_CR25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S2213-8587(18)30020-2","volume":"6","author":"GJ Kahaly","year":"2018","unstructured":"Kahaly GJ, Riedl M, K\u00f6nig J, Pitz S, Ponto K, Diana T, Kampmann E, Kolbe E, Eckstein A, Moeller LC, F\u00fchrer D, Salvi M, Curro N, Campi I, Covelli D, Leo M, Marin\u00f2 M, Menconi F, Marcocci C, Bartalena L, Perros P, Wiersinga WM, European Group on Graves\u2019 Orbitopathy (EUGOGO) (2018) Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves\u2019 orbitopathy (MINGO): a randomised, observer-masked, multicentre trial. Lancet Diabetes Endocrinol 6:287\u2013298","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1141_CR26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/IOP.0000000000000037","volume":"30","author":"JV P\u00e9rez-Moreiras","year":"2014","unstructured":"P\u00e9rez-Moreiras JV, Alvarez-L\u00f3pez A, G\u00f3mez EC (2014) Treatment of active corticosteroid-resistant Graves\u2019 Orbitopathy. Ophthalmic Plast Reconstr Surg 30:162\u2013167","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"1141_CR27","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s40618-018-0847-7","volume":"41","author":"S Sellari-Franceschini","year":"2018","unstructured":"Sellari-Franceschini S, Rocchi R, Marin\u00f2 M, Bajraktari A, Mazzi B, Fiacchini G, Lepri P, Dallan I, Vitti P, Marcocci C (2018) Rehabilitative orbital decompression for Graves\u2019 Orbitopathy: results of a randomized clinical trial. J Endocrinol Invest 41:1037\u20131042","journal-title":"J Endocrinol Invest"},{"key":"1141_CR28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13023-017-0625-1","volume":"12","author":"P Perros","year":"2017","unstructured":"Perros P, Heged\u00fcs L, Bartalena L, Marcocci C, Kahaly GJ, Baldeschi L, Salvi M, Lazarus JH, Eckstein A, Pitz S, Boboridis K, Anagnostis P, Ayvaz G, Boschi A, Brix TH, Curr\u00f2 N, Konuk O, Marin\u00f2 M, Mitchell AL, Stankovic B, T\u00f6r\u00fcner FB, von Arx G, Zarkovi\u0107 M, Wiersinga WM (2017) Graves\u2019 orbitopathy as a rare disease in Europe: a European Group On Graves\u2019 Orbitopathy (EUGOGO) position statement. Orphanet J Rare Dis 12:72","journal-title":"Orphanet J Rare Dis"},{"key":"1141_CR29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/meajo.MEAJO_44_18","volume":"25","author":"YS Ye\u015filta\u015f","year":"2018","unstructured":"Ye\u015filta\u015f YS, G\u00fcnd\u00fcz AK (2018) Idiopathic orbital inflammation: review of literature and new advances. Middle East Afr J Ophthalmol 25:71\u201380","journal-title":"Middle East Afr J Ophthalmol"},{"key":"1141_CR30","doi-asserted-by":"crossref","first-page":"W217","DOI":"10.2214\/AJR.11.7288","volume":"198","author":"M Patnana","year":"2012","unstructured":"Patnana M, Sevrukov AB, Elsayes KM, Viswanathan C, Lubner M, Menias CO (2012) Inflammatory pseudotumor: the great mimicker. Am J Roentgenol 198:W217\u2013W227","journal-title":"Am J Roentgenol"},{"key":"1141_CR31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ncl.2016.08.011","volume":"35","author":"JR Chang","year":"2017","unstructured":"Chang JR, Gruener AM, McCulley TJ (2017) Orbital disease in neuro-ophthalmology. Neurol Clin 35:125\u2013144","journal-title":"Neurol Clin"},{"key":"1141_CR32","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.crad.2011.03.018","volume":"66","author":"ZX Ding","year":"2011","unstructured":"Ding ZX, Lip G, Chong V (2011) Idiopathic orbital pseudotumour. Clin Radiol 66:886\u2013892","journal-title":"Clin Radiol"},{"key":"1141_CR33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00415-015-7926-x","volume":"263","author":"F Montagnese","year":"2016","unstructured":"Montagnese F, Wenninger S, Schoser B (2016) \u201cOrbiting around\u201d the orbital myositis: clinical features, differential diagnosis and therapy. J Neurol 263:631\u2013640","journal-title":"J Neurol"},{"key":"1141_CR34","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/SCS.0000000000000510","volume":"25","author":"J Yan","year":"2014","unstructured":"Yan J, Wu P (2014) Idiopathic orbital myositis. J Craniofac Surg 25:884\u2013887","journal-title":"J Craniofac Surg"},{"key":"1141_CR35","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/ICU.0000000000000515","volume":"29","author":"AK G\u00fcnd\u00fcz","year":"2018","unstructured":"G\u00fcnd\u00fcz AK, Ye\u015filta\u015f YS, Shields CL (2018) Overview of benign and malignant lacrimal gland tumors. Curr Opin Ophthalmol 29:458\u2013468","journal-title":"Curr Opin Ophthalmol"},{"key":"1141_CR36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4329\/wjr.v6.i4.106","volume":"6","author":"MN Pakdaman","year":"2014","unstructured":"Pakdaman MN, Sepahdari AR, Elkhamary SM (2014) Orbital inflammatory disease: pictorial review and differential diagnosis. World J Radiol 6:106\u2013115","journal-title":"World J Radiol"},{"key":"1141_CR37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11910-015-0617-2","volume":"16","author":"SJ Hickman","year":"2016","unstructured":"Hickman SJ (2016) Optic perineuritis. Curr Neurol Neurosci Rep 16:16","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1141_CR38","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jamaophthalmol.2017.1581","volume":"135","author":"I Mombaerts","year":"2017","unstructured":"Mombaerts I, Bilyk JR, Rose GE, McNab AA, Fay A, Dolman PJ, Allen RC, Devoto MH, Harris GJ, Expert Panel of the Orbital Society (2017) Expert Panel of the Orbital Society. Consensus on Diagnostic Criteria of Idiopathic Orbital inflammation using a modified delphi approach. JAMA Ophthalmol 135:769\u2013776","journal-title":"JAMA Ophthalmol"},{"key":"1141_CR39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/archopht.121.4.491","volume":"121","author":"SJ Yuen","year":"2003","unstructured":"Yuen SJ, Rubin PA (2003) Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophtalmol 121:491\u2013499","journal-title":"Arch Ophtalmol"},{"key":"1141_CR40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0033-8389(05)70084-1","volume":"37","author":"AL Weber","year":"1999","unstructured":"Weber AL, Romo LV, Sabates NR (1999) Pseudotumor of the orbit. Clinical, pathologic, and radiologic evaluation. Radiol Clin N Am 37:151\u2013168","journal-title":"Radiol Clin N Am"},{"key":"1141_CR41","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","volume":"336","author":"LS Newman","year":"1997","unstructured":"Newman LS, Rose CS, Maier LA (1997) Sarcoidosis. N Engl J Med 336:1224\u20131234","journal-title":"N Engl J Med"},{"key":"1141_CR42","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1001\/jama.289.24.3300","volume":"289","author":"KW Thomas","year":"2003","unstructured":"Thomas KW, Hunninghake GW (2003) Sarcoidosis. JAMA 289:3300\u20133303","journal-title":"JAMA"},{"key":"1141_CR43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/OARRR.S167783","volume":"11","author":"SG Pasoto","year":"2019","unstructured":"Pasoto SG, de Oliveira Adriano, Martins V, Bonfa E (2019) Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus: links and risks. Open Access Rheumatol 11:33\u201345","journal-title":"Open Access Rheumatol"},{"key":"1141_CR44","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.eye.6701413","volume":"19","author":"A Bhatia","year":"2005","unstructured":"Bhatia A, Yadava U, Goyal JL, Chaturvedi KU (2005) Limited Wegener\u2019s granulomatosis of the orbit: a case study and review of literature. Eye 19:102\u2013104","journal-title":"Eye"},{"key":"1141_CR45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.semarthrit.2007.06.003","volume":"37","author":"JR Lutt","year":"2008","unstructured":"Lutt JR, Lim LL, Phal PM, Rosenbaum JT (2008) Orbital inflammatory disease. Semin Arthritis Rheum 37:207\u2013222","journal-title":"Semin Arthritis Rheum"},{"key":"1141_CR46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.survophthal.2018.08.002","volume":"64","author":"TG Olsen","year":"2018","unstructured":"Olsen TG, Heegaard S (2018) Orbital lymphoma. Surv Ophthalmol 64:45\u201366","journal-title":"Surv Ophthalmol"},{"key":"1141_CR47","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.surneu.2007.07.075","volume":"70","author":"MK Kasliwal","year":"2008","unstructured":"Kasliwal MK, Suri A, Gupta DK, Suri V, Rishi A, Sharma BS (2008) Sphenoid wing inflammatory pseudotumor mimicking a clinoidal meningioma: case report and review of the literature. Surg Neurol 70:509\u2013513","journal-title":"Surg Neurol"},{"key":"1141_CR48","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0161-6420(03)00787-5","volume":"110","author":"P Saeed","year":"2003","unstructured":"Saeed P, Rootman J, Nugent RA, White VA, Mackenzie IR, Koornneef L (2003) Optic nerve sheath meningiomas. Ophtalmology 110:2019\u20132030","journal-title":"Ophtalmology"},{"key":"1141_CR49","first-page":"356","volume":"7","author":"TJ Sullivan","year":"2018","unstructured":"Sullivan TJ (2018) Vascular anomalies of the orbit-A reappraisal. Asia Pac J Ophthalmol (Phila) 7:356\u2013363","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"1141_CR50","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"66","author":"JH Stone","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 66:539\u2013551","journal-title":"N Engl J Med"},{"key":"1141_CR51","doi-asserted-by":"crossref","first-page":"R175","DOI":"10.1530\/EJE-18-1024","volume":"180","author":"M Rotondi","year":"2019","unstructured":"Rotondi M, Carbone A, Coperchini F, Fonte R, Chiovato L (2019) Diagnosis of Endocrine disease: IgG4-related thyroid autoimmune disease. Eur J Endocrinol 180:R175\u2013R183","journal-title":"Eur J Endocrinol"},{"key":"1141_CR52","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s40618-014-0171-9","volume":"37","author":"L Bartalena","year":"2014","unstructured":"Bartalena L, Chiovato L (2014) Graves\u2019-like orbitopathy: do not forget IgG4-related disease. J Endocrinol Invest 37:1233\u20131235","journal-title":"J Endocrinol Invest"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-019-01141-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-019-01141-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-019-01141-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T10:04:23Z","timestamp":1611741863000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-019-01141-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1141"],"URL":"https:\/\/doi.org\/10.1007\/s40618-019-01141-3","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,5]]},"assertion":[{"value":"17 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All diagnostic and therapeutic procedures performed in this study were in accordance with ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the individual participant included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}